Founded in 2013, Health2Sync offers digital solutions to help
people with chronic diseases, pre-diabetes, or weight concerns to manage
their health. The product offerings, including the “Health2Sync
App,” a “Patient Management Platform,” and automated health
engagement solutions, are now the largest in Asia and are proven to help
users improve their blood glucose outcomes.
The "Health2Sync App helps chronic disease patients easily recordtheir blood glucose level, blood pressure, weight, and lifestyle data such as
diet and exercise. Through automated data syncing and analyses, healthcare
professionals can view patients’ data in the “Patient Management
Platform,” which also enables them to provide timely personalized
interventions by identifying patient situations efficiently, realizing
integrated diabetes care.
Health2Sync's achievements include being the first approved digitaltherapeutics in Taiwan for their insulin dosage titration software,
Insultrate, which they co-developed with Sanofi. The company has also
received the “NEXT BIG” Startup title from the Taiwan National
Development Council. With over 1.4 million users worldwide, Health2Sync is
Asia’s leading chronic disease management platform.